4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-22-062858
Chief Commercial Officer sold 734 shares at $15.80 ($11,597)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wettig Thane Chief Commercial Officer | 2022-12-23 | Sale | −734 | $15.80 | $11,597 | 89,163 | D: show line 1 in the form |
| Open-market sales · 734 sh · avg $15.80 · $11,597 | |||||||
Loading xslF345X03/doc4.xml…